Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are eight patents…
Source
New patent for Boehringer Ingelheim drug TRADJENTA Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Spain? Read Post »
Annual Drug Patent Expirations for LIVMARLI Livmarli is a drug marketed by Mirum and is included in one NDA. It is available from one supplier. There are four patents protecting…
Source
Annual Drug Patent Expirations for DAYVIGO Dayvigo is a drug marketed by Eisai Inc and is included in one NDA. It is available from one supplier. There are two patents…
Source
Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are six patents…
Source
This chart shows the pharmaceutical companies with the most patents in Ukraine. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source
Which pharmaceutical companies have the most drug patents in Ukraine? Read Post »
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
Source
Which drugs have supplementary protection certificates in the most countries? Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Romania? Read Post »
Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Llc and is included in three NDAs. It is available from one supplier. There are forty-one patents…
Source
Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen…
Source
Get new actionable insights and updates from BiotechBlog
